Sergey Brin, co-founder of Google, and Anne Wojcicki, co-founder of 23andMe, announced a $50-million challenge spurring existing and new donors at every level to give, or increase giving, to The Michael J. Fox Foundation for Parkinson’s Research. The Challenge is now in effect and will match all new or increased gifts to The Michael J. Fox Foundation on a one-to-one basis through year-end 2012.
Â
MIAMI, August 27, 2009, The Associated Press — An institute at the University of Miami will receive a $20 million gift to research some common but complex disorders including autism and Parkinson's, university officials announced Thursday.
NEW YORK, July 14, 2009 — The Michael J. Fox Foundation for Parkinson's Research today announced approximately $2.1 million in total funding to 10 research teams working to validate therapeutic targets for Parkinson's disease.
June 25, 2009 — As of mid-2009, The Michael J. Fox Foundation for Parkinson’s Research has already funded over $1 million in high-risk, high-reward approaches to Parkinson’s therapeutic development through its groundbreaking Rapid Response Innovation Awards. Projects include investigations of the safety and efficacy of an FDA-approved drug for kidney disease to treat Parkinson’s; characterization of a tenuous link between PD and certain strains of influenza virus; and a proof-of-principle approach to refine deep brain stimulation (DBS) into a potentially more effective symptomatic therapy.
NEW YORK, June 2, 2009 — Weill Cornell Medical College announced today that it has received a US$100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Dr. Kyu Rhee, assistant attending physician in the Division of Infectious Diseases in the Department of Medicine at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and assistant professor in the Department of Microbiology and Immunology at Weill Cornell Medical College, titled "Metabolosomes: The Organizing Principle of Latency in Mycobacterium Tuberculosis."
May 7, 2009 — The Michael J. Fox Foundation for Parkinson’s Research announced a funding commitment of $2 million for Biomarkers 2009. This fourth round of biomarker funding by MJFF aims to continue stimulating discovery of new disease and drug biomarkers. At the same time, recognizing the critical need for an orchestrated, fieldwide strategy to drive tangible progress, MJFF is putting building blocks in place to launch a comprehensive biomarker discovery and verification effort in coming months.
